Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression
MaMiDaPP
Optimizing Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression
1 other identifier
interventional
75
0 countries
N/A
Brief Summary
This study will test the effect of a mobile mindfulness-based intervention on reducing post-cesarean delivery pain and preventing postpartum depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2022
CompletedFirst Posted
Study publicly available on registry
June 1, 2022
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedJune 1, 2022
May 1, 2022
2.8 years
May 27, 2022
May 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postpartum depression
depressive symptoms EPDS 13 or higher
4 weeks - 6 months
Secondary Outcomes (1)
Post-operative pain
4 weeks - 6 months
Study Arms (2)
Mindfulness
EXPERIMENTALReceiving mobile, self-guided mindfulness intervention
Treatment as usual with monitoring
NO INTERVENTIONReceiving treatment as usual with monitoring by study PI and investigators.
Interventions
Meditation training to help reduce stress and reactivity to pain and other stressors.
Eligibility Criteria
You may qualify if:
- years of age, have a singleton pregnancy, score less than 10 on the Edinburgh Postnatal Depression Scale (EPDS; (Cox et al., 1987b), willing to participate in the eight-week intervention or be randomized to the TAUM condition, have no significant psychiatric disorders other than depression or anxiety (e.g., bipolar disorder, substance use disorder, etc.), have no chronic pain condition (e.g., fibromyalgia), and proficient in English or Spanish
You may not qualify if:
- Women who screen 10 or higher on the EPDS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Illinois at Urbana-Champaignlead
- University of Pittsburgh Medical Centercollaborator
- Southern Illinois Universitycollaborator
- Arrowhead Regional Medical Centercollaborator
- Northwestern University Feinberg School of Medicinecollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 27, 2022
First Posted
June 1, 2022
Study Start
July 1, 2023
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
June 1, 2022
Record last verified: 2022-05